Abstract Objective: This study was undertaken to evaluate the changes of the activity of the intestinal mucosal mast cells (IMMC) in multiple organ failure (MOF). Methods: Rat model of the MOF was induced by intraperitoneal injection of zymosan. Both the functional alteration and the pathological morphology of essential organs, including small intestine, liver, kidney and the lungs, were examined, or visualized by light microscopy. The histamine and tumor necrosis factor α (TNF-α) in plasma and small intestinal tissue were detected by the fluorimetric assay and Enzyme-linked immunoadsordent assay, respectively. The ultra structure changes of the IMMC from MOF rat were evaluated by a transmission electronic microscope. Results: Zymosan induced obvious inflammatory morphology and functional impairment in the essential organs in the rats, which is indicative of characteristic changes in the MOF. It showed a significant decreased level of histamine in the intestinal tissue of the MOF rats when compared with the normal controls (11.63±1.97 vs 8.67±1.16 ng/g protein, P<0.01), whereas the plasma histamine level no significant changes. TNF-α level elevated apparently in both intestinal tissue and plasma in MOF rats. Furthermore, the increased number and degranulation of IMMC in the gut tissue were obvious in the MOF rats. Conclusion: These results suggested that the histamine and TNF-α, released from irrelevantly activated IMMC, may play an important role in the development of MOF.

Objective: To study the effect of somatostatin analogue octreotide on the invasion and metastasis of gastric cancer in vitro and in vivo. Methods: Using membrane invasion culture system alone or coated with matrigel, we observed the effect of octreotide on blocking migration and invasion of gastric carcinoma cells. Nude mice implanted orthotopically with SGC-7901 human stomach carcinoma were given injections of octreotide for 8 weeks. MMP-2 was detected by gelatin zymography or RT-PCR. The microvascular density and VEGF expression were examined by immunohistochemical staining with factor VIII antibody and VEGF antibody. Results: Octreotide significantly inhibit migration(49.8

Objective: To investigate effects of Aspirin on the growth of gastric cancer in vitro and in vivo. Methods: The effects of aspirin on the proliferation of SGC-7901 cells were measured by 3H-thymidine incorporation into DNA and cell cycle analysised by flow cytometric analysis, separately. COX-2 protein was examed in SGC-7901 cells by immunohistochemistry. The expression of c-Fos and AP-1 activity were detected by immunoblotting and EMSA separately. Results: Aspirin significantly decreased 3H-thymidine incorporation into SGC-7901 cells. Among concentration of 1

Objectives: Somatostatin and its analogues may suppress the growth of various tumor cells. However, the effect of octreotide on growth of gastric adenocarcinoma is still largely unknown. This study was to explore if octreotide could inhibit the growth of gastric adenocarcinoma and the probable mechanisms behind the effects. Methods: Proliferation of gastric cancer cell line affected with octreotide was determined by 3H-thymidine incorporation. After xenografts of human gastric cancer were implanted orthotopically in stomach, nude mice were administrated octreotide for 8 weeks. The mRNA of somatostatin receptor in the SGC-7901 cells was detected by reverse transcription polymerase chain reaction technique. Extrcellular signal-regulated protein kinase and c-Fos in gastric cancer tissues were measured by immunohistochemistry and western blot. Activator protein-1 binding activity was examined by electrophoretic mobility sift assay. Results: 3H-thymidine incorporation into SGC-7901 cells was significantly decreased by octreotide in a manner of concentration dependence. Either size or weight of tumors treated with octreotide was significantly reduced in vivo. The inhibition rate for tumor was 62.3% in octreotide group. The genes of somatostatin receptor 2 and 3 were expressed in SGC-7901 gastric cancer cell lines. Extracellular signal-regulated protein kinase and the c-Fos protein level were decreased in gastric adenocarcinoma treated with octreotide. Moreover, the fetal calf serum stimulated activator protein-1 binding activity could be suppressed by octreotide potentially. Conclusions: Inhibition of sequential molecular events in MAPK pathway may interpret the mechanisms behind the suppressive effect of octreotide on the growth of gastric adenocarcinoma.

To observe the effect of vasoactive intestinal peptide(VIP) or somatostatin (SST) on the lymphocytes traffic in gut-associated lymphoid tissues in rat, 18 rats were divided into three groups at random. VIP and SST were continuously infused from femoral vein at a dose of 60 pmol/h for 7 h. It was found that the lymphocytes in intestinal lymph collected in 5 hours were significantly reduced after VIP and SST administration(P<0.05). Although the volume decreasing of intestinal lymph was happened in all groups, no significant changes in lymph flow were observed in control and treat groups. The percentages of CD8+ cells in intestinal lymph of rat treated by VIP or SST was markedly lower than that in control group (P<0.05). Finally, either VIP or SST infusion reduced CD8+ cells in the small intestinal mucosa when compared with control. It concludes that either VIP or SST not only reduces lymphocytes, especially CD8+ cells traffic from intestinal mucosa immune system to other organs and systemic immune system but also suppresses the homing of CD8+lymphocytes into intestinal mucosa immune system in rats.